InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-31.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Lamattina John l, 董事. Insider active across 2 companies, notably Immunome Inc.. Cumulatively, 12 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €379k. History available since 24 May 2021. The latest transaction was filed on 6 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lamattina John l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
2,161 股@ US$114.1525.2% 占其流量Common StockSEC:0002001011-26-000036:0
2,161 股@ US$200.7644.3% 占其流量Common StockSEC:0002001011-26-000036:1
2,145 股@ US$66.1312.7% 占其流量Common StockSEC:0002001011-25-000097:0
1,209 股0Common StockSEC:0002001011-25-000044:0
2,406 股@ US$52.3030.4% 占其流量Common StockSEC:0002001011-24-000093:0
1,252 股0Common StockSEC:0002001011-24-000059:0
1,142 股0Common StockSEC:0000886163-23-000042:0
15,125 股@ US$4.0084.5% 占其流量Common StockSEC:0001104659-23-004007:0
1,004 股0Common StockSEC:0000886163-22-000079:0
4,835 股@ US$32.3014.2% 占其流量Common StockSEC:0000886163-21-000136:0
630 股0Common StockSEC:0000886163-21-000089:0
338 股@ US$18.448.4% 占其流量Common StockSEC:0001104659-21-072617:0
标准退出：2021年8月22日 (T+90)
12 条申报中的 12 条
About Lamattina John l
LAMATTINA JOHN L is Administrateur of Ligand Pharmaceuticals INC and Immunome Inc. He has 12 filings in total, and across the sampled recent filings they span from 2021-05-26 to 2026-03-31, with EUR 5103 in buys and EUR 373742 in sales, and the modal transaction nature is Attribution.
